Etodolac and Post-bleaching Sensitivity

NCT02881619 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Medicaments Substances in Therapeutic Use

Interventions

DRUG: Etodolac
DRUG: Placebo

Sponsor

Flavia Pardo Salata Nahsan